Legat, FJ; Gruber-Wackernagel, A; Hofer, A; Waltner, K; Wolf, P.
APREPITANT, A NK1-ANTAGONIST, ADMINISTERED FOR 16 WEEKS REDUCED ITCH AND SUPPORTED RESOLUTION OF SKIN LESIONS IN A PATIENT WITH CHRONIC PRURIGO
ACTA DERM-VENEREOL. 2017; 97(8):1028-1028.-9th World Congress on Itch 2017; OCT 15-17, 2017; Wroclaw, Poland.
[Oral Communication]
Web of Science